Search Results

You are looking at 51 - 60 of 109 items for :

  • "cardiac hypertrophy" x
Clear All
Free access

Cássio M Villicev, Fatima R S Freitas, Marcelo S Aoki, Cássio Taffarel, Thomas S Scanlan, Anselmo S Moriscot, Miriam O Ribeiro, Antonio C Bianco and Cecília H A Gouveia

×T3 resulted in cardiac hypertrophy, characterised by an increase in the dry mass of the heart (33 and 46% vs control respectively), while GC-1 treatment had no effect. Discussion The present study shows that treatment

Free access

Daniel Landau, Chen Chayat, Nili Zucker, Eli Golomb, Channa Yagil, Yoram Yagil and Yael Segev

cardiac hypertrophy in transgenic animal models . Methods in Molecular Medicine 112 339 – 352 . Boluyt MO Long X Eschenhagen T Mende U Schmitz W Crow MT Lakatta EG 1995 Isoproterenol infusion induces alterations in expression of hypertrophy

Free access

Rebecca M Reynolds and Adrienne Gordon

not completely understood, data from animal models, support a causal relationship between in utero exposure to maternal obesity and pathological left ventricular cardiac hypertrophy, hypertension and impaired systolic and diastolic function in the

Free access

Natasha N Chattergoon

Gloss B Swanson EA Dillmann WH 2007 Adeno-associated virus-mediated expression of thyroid hormone receptor isoforms-alpha1 and -beta1 improves contractile function in pressure overload-induced cardiac hypertrophy . Endocrinology 148

Free access

Stefan Groeneweg, Robin P Peeters, Theo J Visser and W Edward Visser

is efficiently taken up by rat cardiomyocytes ( Medina-Gomez et al. 2008 ), but is a less potent regulator of TH target genes in the heart than T 3 ( Liang et al. 1997 ). Nevertheless, high doses of TA 4 induce cardiac hypertrophy in rats

Free access

Timothy J Cole and Morag J Young

showed that cardiomyocyte MR null also contributed to electromechanical responses to cardiac hypertrophy and damage at least in part due to changes in NHE-1 levels and phosphorylation of Calcium/calmodulin kinase 2 (CamKs) ( Bienvenu et al . 2015

Free access

Damian G Romero, Ming Yi Zhou, Licy L Yanes, Maria W Plonczynski, Tanganika R Washington, Celso E Gomez-Sanchez and Elise P Gomez-Sanchez

to adapt to acute ventricular pressure overload and cardiac hypertrophy caused by transverse aortic constriction ( Rogers et al. 1999 ). Cardiac RGS4 is involved in diabetic cardiomyopathy since its overexpression confers resistance to

Open access

Rachel V Richardson, Emma J Batchen, Adrian J W Thomson, Rowan Darroch, Xinlu Pan, Eva A Rog-Zielinska, Wiktoria Wyrzykowska, Kathleen Scullion, Emad A S Al-Dujaili, Mary E Diaz, Carmel M Moran, Christopher J Kenyon, Gillian A Gray and Karen E Chapman

(VSM) MR knockout is protective against age-related hypertension and cardiac hypertrophy, it has negligible effect on blood pressure and heart size in young mice (<7 months of age) ( McCurley et al . 2012 ). The physiological role of GR in the

Restricted access

Kehinde Samuel Olaniyi and Lawrence Aderemi Olatunji

, cardiac hypertrophy and liver disease among others, and its beneficial effects have been linked to its anti-inflammatory and antioxidant properties ( Grau et al. 2011 , Million et al . 2013 , Olaniyi & Olatunji 2019 ). Therefore, the present study

Free access

Sung Wook Park, Shawna D Persaud, Stanislas Ogokeh, Tatyana A Meyers, DeWayne Townsend and Li-Na Wei

mouse model ( Zhang et al . 2002 , 2003 ), suggesting that CRABP1 may prevent cardiac hypertrophy and failure, in part, by dampening the activity of CaMKII. This study reveals that CRABP1 is a new physiological regulator of CaMKII and is critical to